-
1Academic Journal
المؤلفون: Huot, Nicolas, Planchais, Cyril, Rosenbaum, Pierre, Contreras, Vanessa, Jacquelin, Beatrice, Petitdemange, Caroline, Lazzerini, Marie, Beaumont, Emma, Orta-Resendiz, Aurelio, Rey, Félix, Reeves, R. Keith, Le Grand, Roger, Mouquet, Hugo, Müller-Trutwin, Michaela
المساهمون: HIV, Inflammation et persistance - HIV, Inflammation and Persistence, Institut Pasteur Paris (IP)-Université Paris Cité (UPCité), Immunologie humorale - Humoral Immunology, Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Immunologie des maladies virales, auto-immunes, hématologiques et bactériennes (IMVA-HB), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Virologie Structurale - Structural Virology, Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Harvard Medical School Boston (HMS), Duke University School of Medicine Durham, NC, USA, Beth Israel Deaconess Medical Center Boston (BIDMC), Ragon Institute of MGH, MIT and Harvard, C. Petitdemange was supported by the Pasteur-Roux Cantarini fellowship, the Young Investigator Sidaction fellowship and the National Institutes of Health (NIH) grant (R01AI143457). A.O.R. and E.B. received a doctoral fellowship from the Université Paris Cité and the Ministère français de lʼEnseignement supérieur, de la Recherche et de lʼInnovation. This work was supported by the ‘URGENCE COVID-19’ fundraising campaign of Institut Pasteur. H.M. received core funding from the Institut Pasteur and the INSERM and was supported by grants from the ANR REACTing Covid19 (20RR028-00), the European Commission Horizon 2020 program (RECoVER project, 101003589), the Institut Pasteur Task Force COVID-19 (2019-NCOV THERAMAB project) and the Fondation de France (00106077). Furthermore, we would like to acknowledge the support from NIH under grants R01DK130472 and R01AI143457 to R.K.R. We gratefully acknowledge the support of Institut Pasteur and Gilead for the purchase of the Fortessa equipment. We are grateful for the support of IDMIT by the French government—Investments for the Future program for infrastructures (PIA) through the ANR-11-INBS-0008 grant as well as from the PIA grant ANR-10-EQPX-02-01 to the FlowCyTech facility at IDMIT. We equally acknowledge the Investments for Future grant ANR-10-INSB-04 to support the UtechS Photonic BioImaging (Imagopole) and C2RT facilities at Institut Pasteur., ANR-11-INBS-0008,IDMIT,Infrastructure nationale pour la modélisation des maladies infectieuses humaines(2011), ANR-10-EQPX-0002,FlowCyTech,Plateforme de phénotypage en Mass cytométrie pour l'analyse multiparamétrique de biomarqueurs complexes de l'efficacité de nouvelles stratégies thérapeutiques ou vaccinales(2010), European Project: 101003589, H2020-SC1-PHE-CORONAVIRUS-2020,RECOVER(2020)
المصدر: ISSN: 1529-2908.
مصطلحات موضوعية: [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, [SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology, [SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
Relation: info:eu-repo/semantics/altIdentifier/pmid/37919524; info:eu-repo/grantAgreement//101003589/EU/Rapid European COVID-19 Emergency Response research/RECOVER; PUBMED: 37919524; PUBMEDCENTRAL: PMC10681903
-
2Academic Journal
المؤلفون: Rascle, Philippe, Planchais, Cyril, Jacquelin, Béatrice, Lazzerini, Marie, Contreras, Vanessa, Passaes, Caroline, Saez-Cirion, Asier, Mouquet, Hugo, Huot, Nicolas, Müller-Trutwin, Michaela
المساهمون: Université Paris Diderot, Sorbonne Paris Cité, Paris, France, Université Paris Diderot - Paris 7 (UPD7), HIV, Inflammation et persistance - HIV, Inflammation and Persistence, Institut Pasteur Paris (IP)-Université Paris Cité (UPCité), Immunologie humorale - Humoral Immunology, Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Immunologie des Maladies Virales et Autoimmunes (IMVA - U1184), Université Paris-Sud - Paris 11 (UP11)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM), NH was supported by the Fondation J. Beytout and Institut Pasteur. PR was recipient of a PhD fellowship from the University Paris Diderot, Sorbonne Paris Cité and supported by the NIH (R01AI143457) and Institut Pasteur. CaP was recipient of a Roux-Cantarini Postdoctoral Fellowship. Cy.P. was the recipient of an ANRS post-doctoral fellowship. We would like to acknowledge grant support from Sidaction and ANRS to MMT. H.M. received core grants from the Institut Pasteur, the INSERM and the Milieu Intérieur Program (ANR-10-LABX-69-01) and was supported by an ANRS grant. We gratefully acknowledge the support to IDMIT from the French government: Investments for the Future program for infrastructures (PIA) through the ANR-11-INBS-0008 grant as well as from the PIA grant ANR-10-EQPX-02-01 to the FlowCyTech facility at IDMIT. We equally acknowledge the Investments for Future grant ANR-10–INSB–04 to support the UtechS Photonic BioImaging (Imagopole) and C2RT facilities at Institut Pasteur., ANR-10-LABX-0069,MILIEU INTERIEUR,GENETIC & ENVIRONMENTAL CONTROL OF IMMUNE PHENOTYPE VARIANCE: ESTABLISHING A PATH TOWARDS PERSONALIZED MEDICINE(2010), ANR-11-INBS-0008,IDMIT,Infrastructure nationale pour la modélisation des maladies infectieuses humaines(2011), ANR-10-EQPX-0002,FlowCyTech,Plateforme de phénotypage en Mass cytométrie pour l'analyse multiparamétrique de biomarqueurs complexes de l'efficacité de nouvelles stratégies thérapeutiques ou vaccinales(2010), ANR-10-INBS-0004,France-BioImaging,Développment d'une infrastructure française distribuée coordonnée(2010)
المصدر: ISSN: 2399-3642 ; Communications Biology ; https://pasteur.hal.science/pasteur-04129134 ; Communications Biology, 2022, 5 (1), pp.674. ⟨10.1038/s42003-022-03619-y⟩.
مصطلحات موضوعية: MESH: Animals, MESH: Chlorocebus aethiops, MESH: HIV Infections, MESH: Immunoglobulin A, MESH: Intestinal Mucosa, MESH: Killer Cells, Natural, MESH: Lymph Nodes, MESH: Simian Immunodeficiency Virus, [SDV]Life Sciences [q-bio]
Relation: info:eu-repo/semantics/altIdentifier/pmid/35798936; PUBMED: 35798936; PUBMEDCENTRAL: PMC9262959
-
3Academic Journal
المؤلفون: Rascle, Philippe, Jacquelin, Béatrice, Petitdemange, Caroline, Contreras, Vanessa, Planchais, Cyril, Lazzerini, Marie, Dereuddre-Bosquet, Nathalie, Le Grand, Roger, Mouquet, Hugo, Huot, Nicolas, Müller-Trutwin, Michaela
المساهمون: Université Paris Diderot, Sorbonne Paris Cité, Paris, France, Université Paris Diderot - Paris 7 (UPD7), HIV, Inflammation et persistance - HIV, Inflammation and Persistence, Institut Pasteur Paris (IP), Immunologie des Maladies Virales et Autoimmunes (IMVA - U1184), Université Paris-Sud - Paris 11 (UP11)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Infectious Diseases Models for Innovative Therapies (IDMIT), Université Paris-Saclay-Institut de Biologie François JACOB (JACOB), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Immunologie humorale - Humoral Immunology, Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), NH was supported by the Fondation Beytout and Institut Pasteur. PR was recipient of a PhD fellowship from the University Paris Diderot, Sorbonne Paris Cité and also supported by the NIH (R01AI143457) and Institut Pasteur. CaP was recipient of a Roux-Cantarini Postdoctoral Fellowship. CyP was supported by the ERC-2013-StG 337146 program. We would like to acknowledge grant support from ANRS, the Fondation J. Beytout, MSD Avenir, the Fondation Les Ailes and from the NIH (R01AI143457) to MMT. IDMIT infrastructure is supported by the “Program Investissements d’Avenir” (PIA), managed by the ANR under reference ANR-11-INBS-0008 and by the PIA grant ANR-10-EQPX-02-01. We equally acknowledge the Investments for Future grant ANR-10–INSB–04 to support the UtechS Photonic BioImaging (Imagopole) and C2RT facilities at Institut Pasteur., ANR-11-INBS-0008,IDMIT,Infrastructure nationale pour la modélisation des maladies infectieuses humaines(2011), ANR-10-EQPX-0002,FlowCyTech,Plateforme de phénotypage en Mass cytométrie pour l'analyse multiparamétrique de biomarqueurs complexes de l'efficacité de nouvelles stratégies thérapeutiques ou vaccinales(2010), ANR-10-INBS-0004,France-BioImaging,Développment d'une infrastructure française distribuée coordonnée(2010), European Project: 337146,EC:FP7:ERC,ERC-2013-StG,HUMANTIVIRUSES(2014)
المصدر: EISSN: 2589-0042 ; iScience ; https://pasteur.hal.science/pasteur-03682118 ; iScience, 2021, 24 (10), pp.103109. ⟨10.1016/j.isci.2021.103109⟩
مصطلحات موضوعية: immunology, virology, [SDV]Life Sciences [q-bio], [SDV.IMM]Life Sciences [q-bio]/Immunology
Relation: info:eu-repo/semantics/altIdentifier/pmid/34622162; info:eu-repo/grantAgreement/EC/FP7/337146/EU/Human Antibody Responses to Viruses/HUMANTIVIRUSES; PUBMED: 34622162; PUBMEDCENTRAL: PMC8479784
-
4Academic Journal
المؤلفون: Terrade, Gauthier, Huot, Nicolas, Petitdemange, Caroline, Lazzerini, Marie, Orta Resendiz, Aurelio, Jacquelin, Beatrice, Müller-Trutwin, Michaela
المساهمون: HIV, Inflammation et persistance - HIV, Inflammation and Persistence, Institut Pasteur Paris (IP)-Université Paris Cité (UPCité), École Doctorale Bio Sorbonne Paris Cité Paris (ED562 - BioSPC), Université Sorbonne Paris Cité (USPC)-Université Paris Cité (UPCité), G.T. was partially supported by Institut Pasteur and by a NIH grant (R01AI143457). N.H. was supported by the Fondation J. Beytout, the Institut Pasteur and a NIH grant (R01AI143457). C.P. was supported by a Roux-Cantarini fellowship and Institut Pasteur. A.O.R. was supported by a doctoral fellowship from the University of Paris.
المصدر: EISSN: 2076-393X ; Vaccines ; https://pasteur.hal.science/pasteur-03496409 ; Vaccines, 2021, This article belongs to the Special Issue Non-human Primate Research in Immune Modulation and Drug Discovery, 9 (9), pp.958. ⟨10.3390/vaccines9090958⟩
مصطلحات موضوعية: HIV, SIV, animal model, cure, immunity, natural host, non-human primate, therapies, [SDV]Life Sciences [q-bio]
Relation: info:eu-repo/semantics/altIdentifier/pmid/34579195; pasteur-03496409; https://pasteur.hal.science/pasteur-03496409; https://pasteur.hal.science/pasteur-03496409/document; https://pasteur.hal.science/pasteur-03496409/file/vaccines-09-00958-v3.pdf; PUBMED: 34579195; PUBMEDCENTRAL: PMC8472852